This site contains promotional content intended for UK Healthcare Professionals and other relevant decision makers | Not a HCP? Visit our  Public Site.

Adverse Event reporting can be found at the bottom of the page | Prescribing Information for the relevant medicine can be found adjacent to the below content and/or in the footer below. 

Cardiovascular
Cardiovascular
Womens Health
Women's Health
two kidneys
Nephrology
Oncology
Oncology
Ophthalmology
Ophthalmology
Respiratory
Respiratory
Bayer for ProfessionalsYour Resource Portal

Ophthalmology Resources | PP-EYL-GB-2417, August 2024

EYLEA® (aflibercept) Risk Minimisation Materials
Visit to access Risk Minimisation Materials for EYLEA® (aflibercept)
PP-EYL-GB-2647, December 2024
Ophthalmology Patient Support Materials
Access our range of downloadable patient support booklets and other resources
PP-EYL-GB-3058, December 2025
Retinal Pioneers Programme
A source of on-demand, educational resources developed in collaboration with national and international thought leaders
PP-EYL-GB-3029, November 2025
Real World Experience
Practical insights into the experiences of clinicians implementing treatment with EYLEA® (aflibercept) 8 mg in the UK
PP-EYL-GB-3051, December 2025
Ophthalmology Resources
Access useful, downloadable ophthalmology resources
PP-EYL-GB-3011, October 2025